Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

Press releases published on June 8, 2026

Jun. 8, 2026

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Indeterminate GlobeNewswire

Jun. 8, 2026

HP Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Employee Experience (DEX) Management Tools

Indeterminate GlobeNewswire

Jun. 8, 2026

Shattuck Labs Announces Phase 1 Results for SL-325

Indeterminate GlobeNewswire

Jun. 8, 2026

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion 

Indeterminate GlobeNewswire

Jun. 8, 2026

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

Indeterminate GlobeNewswire

Jun. 8, 2026

Yeahka (9923.HK) Q1 Overseas Payment GPV Surges Nearly Fourfold to RMB2,439 Million

Indeterminate GlobeNewswire

Jun. 8, 2026

Intravacc stellt integrierte analytische Kompetenzen zur Beschleunigung der Entwicklung von Impfstoffen und Biologika vor

Indeterminate GlobeNewswire

Jun. 8, 2026

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Indeterminate GlobeNewswire

Jun. 8, 2026

Realtek Joins OpenTitan Coalition to Develop Discrete Hardware Root of Trust Devices

Indeterminate GlobeNewswire

Jun. 8, 2026

Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia

Indeterminate GlobeNewswire

Jun. 8, 2026

Reminder: Nicox June 2024 Warrants will expire June 19, 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

Rappel : les BSA Nicox de juin 2024 expireront le 19 juin 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

Communiqué de presse : Sarclisa en formulation sous-cutanée de Sanofi approuvé dans l’UE comme premier traitement anticancéreux administré via un injecteur portable

Indeterminate GlobeNewswire

Jun. 8, 2026

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Indeterminate GlobeNewswire

Jun. 8, 2026

Digital Realty Launches Malaysia Operations to Advance Southeast Asia’s Digital Connectivity

Indeterminate GlobeNewswire